Table 1 Participant characteristics
Characteristics | Statistic |
|---|---|
Age (years), mean (range) | 34 (21–46) |
Years diagnosed with RA, median (IQR) | 10 (2–16) |
Language, n (%) | |
English | 20 (95) |
French | 1 (5) |
Canadian province of residence, n (%) | |
British Columbia | 9 (43) |
Ontario | 7 (33) |
Nova Scotia | 2 (10) |
Other (i.e. Alberta, New Brunswick, Québec) | 3 (14) |
Geographic residencea | |
Rural | 5 (24) |
Urban | 16 (76) |
Ancestry, n (%)b | |
White | 15 (71) |
Asian | 5 (24) |
Black | 1 (5) |
Hispanic | 1 (5) |
Indigenous | 1 (5) |
Highest level of education, n(%) | |
Post-secondary (university, college, technical school, etc.) | 21 (100) |
Current employment status, n (%)b | |
Employed full time (40 or more hours per week) | 14 (67) |
Student | 4 (19) |
Employed part time (less than 40 hours per week) | 2 (10) |
Unable to work | 2 (10) |
Unemployed and looking for work | 1 (5) |
Household income (CAD dollars), n (%)c | |
150,000 and over | 5 (25) |
120,000 to 150,000 | 2 (10) |
90,000 to 120,000 | 6 (30) |
60,000 to 90,000 | 2 (10) |
30,000 to 60,000 | 5 (25) |
Current members of household, median (IQR) | 3 (2 – 4) |
Marital status, n (%) | |
Married | 13 (62) |
Common-law or co-habiting | 5 (24) |
Single, never married | 3 (14) |
Plan to have future children, n (%) | 12 (57) |
Future family planning options considered, n (%)b | |
Childbearing | 12 (100) |
Adoption | 5 (42) |
Other (i.e. surrogacy or assisted fertilisation) | 4 (33) |
Medications taken for RA, n (%)b, d | |
Traditional DMARDs | |
Antimalarials (i.e. hydroxychloroquine, chloroquine) | 19 (91) |
Methotrexate | 15 (71) |
Sulfasalazine | 14 (67) |
Leflunomide | 4 (19) |
Azathioprine | 2 (10) |
Gold salts | 1 (5) |
Cyclosporine | 1 (5) |
Targeted DMARDs | |
Anti-tumour necrosis factor (anti-TNF) agents | 13 (62) |
Others (e.g. abatacept, rituximab, tocilizumab, tofacitinib) | 7 (33) |